A slow drug-release system has proven highly effective in treating certain bladder cancer patients whose tumors were previously unresponsive to therapy. A new targeted drug delivery system known as TA ...

Non-profit patient advocacy groups, patient groups and others in various parts of the world have come together to launch a community-run buyers' club to access a new generic version of a lifesaving ...

Objectives To examine the association between exposure to greenness and hospital admissions for mental disorders, and to ...

Iain Cheeseman and colleagues reveal the underappreciated role of single genes producing multiple proteins in atypical ...

Sixty-three thousand dollars for a broken ankle and a cut to the knee, with no head injury or internal damage,” Lauren Hughes ...

SITC abstracts highlight updated immunogenicity results from the Phase 2 AMPLIFY-7P trial of ELI-002 7P and preclinical data on the use of ...

NHS leaders in Staffordshire hope a renewed vaccination drive will help keep hospital admissions under control this winter.

THE festive season is fast approaching – a time of joy, celebration and, often, increased alcohol consumption. But “heavy ...

"He reported worsening mobility over the past six months. He had not had medical care in many years. I saw him, and to me, ...

About 50% of people don't respond to first-line treatments for depression. There's a lot of heterogeneity of treatment ...

Adopting the proper countermeasures to protect and maintain trust in health care data will require additional collaboration ...

VANCOUVER, BC / ACCESS Newswire / November 4, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that its wholly owned German subsidiary, ...